CheckMyRecalls

HemoCue AB recalls The HemoCue Glucose 201 Microcuvettes are designed…

HemoCue AB recalls The HemoCue Glucose 201 Microcuvettes are designed for use with the…

Published
9 Jul 2025
Units affected
4 Boxes
Agency
FDA
Country
United States

The hazard

Glucose microcuvettes experienced transit time outside of limits, so stability through the whole microcuvette lifetime can no longer be guaranteed. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency, and purity of the product. This failure could increase the probability of an incorrect test result or a delayed test result.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

The HemoCue Glucose 201 Microcuvettes are designed for use with the HemoCue Glucose 201 (or DM) Analyzer with plasma conversion that multiplies the measured whole blood glucose value by a factor of 1.112 and displays a plasma equivalent glucose result. HemoCue Glucose 201 Microcuvettes are available in individual packages or in vials. The box contains 4 vials with 25 microcuvettes in each vial.

Brand / company
HemoCue AB
Codes / lots
UDI-DI: 07311091107060, Lot: 2501708 (Only 4 boxes within specific McKesson Shipment)
Distribution
US Nationwide distribution in the state of AR.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.